© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Expert Interviews
What Happened to All Those Hospital Drug Shortages?
June 19, 2021
Civica Rx CEO Martin VanTrieste says Civica’s members are experiencing fewer shortages because of strategies used by the company.
Newer Targeted Therapies for HER2+ Metastatic Breast Cancer
June 15, 2021
Ian E. Krop, MD, PhD, of Dana-Faber Cancer Institute, highlights more recent targeted therapy approvals for HER2-positive metastatic breast cancer and describes how each therapy is designed to work.
Frontline Treatment Options for HER2+ Metastatic Breast Cancer
June 15, 2021
Frontline therapies available for newly diagnosed HER2-positive metastatic breast cancer and variables that impact treatment selection.
Positive Results for Vyxeos in Combination With Other Drugs Reported at ASCO Meeting
June 06, 2021
Phase 1b results show manageable toxicities with Venclexta and Rydapt.
Looking Ahead in the Treatment of NSCLC
June 01, 2021
Paul K. Paik, MD, considers the future of MET-directed therapies in non-small cell lung cancer.
Implications of the VISION Trial for Clinical Practice
June 01, 2021
Paul K. Paik, MD, discusses how the results of the VISION trial and the recent FDA approval of tepotinib will impact clinical practice.
The VISION Trial
June 01, 2021
An expert in non-small cell lung cancer discusses the key efficacy and safety findings from the VISION trial of tepotinib in patients with NSCLC and MET exon 14 skipping alterations.
The Role of MET in NSCLC
June 01, 2021
A key opinion leader thoracic oncology reviews the clinical significance of MET exon 14 skipping in NSCLC as well as recent advances in MET-directed therapy.
NSCLC: Targeted Therapy Landscape
June 01, 2021
Paul K. Paik, MD, discusses currently available targeted therapies for patients with NSCLC.
The Best Practices in Creating a Patient-Centric Health System According to Chris Evanguelidi of Redpoint Global
May 31, 2021
Briana Contreras, associate editor of Managed Healthcare Executive, spoke with Chris Evanguelidi, head of healthcare at Redpoint Global, about the best practices for closing the healthcare experience gap and devising an effective patient engagement strategy through a more patient-centric health system.